QQ客服 官方微博 反馈留言

	circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer
	Liang, Yiran; Song, Xiaojin; Li, Yaming; Su, Peng; Han, Dianwen; Ma, Tingting; Guo, Renbo; Chen, Bing; Zhao, Wenjing; Sang, Yuting
刊名	ONCOGENE
	2019
卷号	38期号:42页码:6850-6866
DOI	10.1038/s41388-019-0926-z
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4556771
专题	山东大学
作者单位	1.[Liang, Yiran 2.Song, Xiaojin 3.Li, Yaming 4.Han, Dianwen 5.Ma, Tingting 6.Sang, Yuting 7.Zhang, Ning 8.Li, Xiaoyan 9.Zhang, Hanwen 10.Liu, Ying
推荐引用方式 GB/T 7714	Liang, Yiran,Song, Xiaojin,Li, Yaming,et al. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer[J]. ONCOGENE,2019,38(42):6850-6866.
APA	Liang, Yiran.,Song, Xiaojin.,Li, Yaming.,Su, Peng.,Han, Dianwen.,...&Geng D.(2019).circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.ONCOGENE,38(42),6850-6866.
MLA	Liang, Yiran,et al."circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer".ONCOGENE 38.42(2019):6850-6866.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。